Athyros, V.G. Alexandrides, T.K. Bilianou, H. Cholongitas, E. Doumas, M. Ganotakis, E.S. Goudevenos, J. Elisaf, M.S. Germanidis, G. Giouleme, O. Karagiannis, A. Karvounis, C. Katsiki, N. Kotsis, V. Kountouras, J. Liberopoulos, E. Pitsavos, C. Polyzos, S. Rallidis, L.S. Richter, D. Tsapas, A.G. Tselepis, A.D. Tsioufis, K. Tziomalos, K. Tzotzas, T. Vasiliadis, T.G. Vlachopoulos, C. Mikhailidis, D.P. Mantzoros, C., The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement, Metabolism: Clinical and Experimental, (71), 17-32, 2017, W.B. Saunders, 0026-0495